Rand Sutherland

Dr. Sutherland joined Translate Bio in 2021 as President. Formerly, Dr. Sutherland served for seven years at Sanofi Genzyme, most recently as Global Head of Medical Affairs, and prior to that Head of the Rare Diseases Development therapeutic area. Dr. Sutherland’s strategic leadership in clinical development and medical affairs has been critical to the development and launch of medicines for lysosomal storage diseases, rare blood and other genetic diseases, and pulmonary and immunological diseases. Before joining industry, Dr. Sutherland was Professor of Medicine at the University of Colorado and Chief of Pulmonary and Critical Care Medicine at National Jewish Health in Denver, where he cared for patients and led an NIH-funded clinical and translational research program focused on severe asthma and other complicated pulmonary diseases. Dr. Sutherland earned a BA from Oberlin College, an MPH from the Harvard School of Public Health, and his MD from the University of Chicago. He completed his post-doctoral training in Internal Medicine at the University of California, San Francisco and completed a fellowship in Pulmonary and Critical Care Medicine at the University of Colorado.